Feifan Xiao1,2, Qiufen Wei3, Bingbing Wu4, Xu Liu1, Aiyao Mading1, Lin Yang4, Yan Li3, Fang Liu5, Xinnian Pan3, Huijun Wang4. 1. Depatment of Neonatology, Children's Hospital of Fudan University, Shanghai 201102, China. 2. Center for Molecular Medicine, Children's Hospital of Fudan University; Institutes of Biomedical Sciences, Fudan University, Shanghai 201102, China. 3. The Maternal & Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China. 4. Center for Molecular Medicine, Children's Hospital of Fudan University, Shanghai 201102, China. 5. Cardiovascular center, Children's Hospital of Fudan University, Shanghai 201102, China.
Abstract
BACKGROUND: FLNC encodes actin-binding protein and is mainly concentrated in skeletal and cardiac muscle. Mutations in FLNC were found in cardiomyopathies. To date, studies on FLNC-cardiomyopathies have mainly been reported in adults. There are limited studies that have investigated FLNC variants in pediatric patients with cardiomyopathies. METHODS: We summarized the patients who carried rare variants of FLNC from May 2016 to May 2019 in the Center for Molecular Medicine, Children's Hospital of Fudan University, from clinical exome sequencing data. RESULTS: A total of 5 patients with FLNC rare variants were included. Of them, 3 were male and 2 were female. The median age was 3 months (range from 19 days to 30 months). A1186V was a known pathogenic variant reported in pediatric patients with cardiomyopathy (PMID: 29858533), and the other four variants were novel. In the four novel variants, there are one splicing (c.2265+4del) and three missense (p.R441I, p.C1639Y, and p.A2648S). Two patients (patients 1 and 3) were diagnosed with restrictive cardiomyopathy, two patients (patients 2 and 5) were diagnosed with dilated cardiomyopathy, and one patient (patient 4) was diagnosed with arrhythmia. CONCLUSIONS: All five patients have survived to date. In summary, FLNC rare variants identified by clinical exome sequencing provide genetic evidence to make early diagnosis of cardiomyopathy in infant patients. 2020 Translational Pediatrics. All rights reserved.
BACKGROUND: FLNC encodes actin-binding protein and is mainly concentrated in skeletal and cardiac muscle. Mutations in FLNC were found in cardiomyopathies. To date, studies on FLNC-cardiomyopathies have mainly been reported in adults. There are limited studies that have investigated FLNC variants in pediatric patients with cardiomyopathies. METHODS: We summarized the patients who carried rare variants of FLNC from May 2016 to May 2019 in the Center for Molecular Medicine, Children's Hospital of Fudan University, from clinical exome sequencing data. RESULTS: A total of 5 patients with FLNC rare variants were included. Of them, 3 were male and 2 were female. The median age was 3 months (range from 19 days to 30 months). A1186V was a known pathogenic variant reported in pediatric patients with cardiomyopathy (PMID: 29858533), and the other four variants were novel. In the four novel variants, there are one splicing (c.2265+4del) and three missense (p.R441I, p.C1639Y, and p.A2648S). Two patients (patients 1 and 3) were diagnosed with restrictive cardiomyopathy, two patients (patients 2 and 5) were diagnosed with dilated cardiomyopathy, and one patient (patient 4) was diagnosed with arrhythmia. CONCLUSIONS: All five patients have survived to date. In summary, FLNC rare variants identified by clinical exome sequencing provide genetic evidence to make early diagnosis of cardiomyopathy in infant patients. 2020 Translational Pediatrics. All rights reserved.
Authors: Sahej Bains; David J Tester; Samuel J Asirvatham; Peter A Noseworthy; Michael J Ackerman; John R Giudicessi Journal: Mayo Clin Proc Date: 2019-03-29 Impact factor: 7.616
Authors: Ritika Sethi; Jonne Seppälä; Helena Tossavainen; Mikko Ylilauri; Salla Ruskamo; Olli T Pentikäinen; Ulla Pentikäinen; Perttu Permi; Jari Ylänne Journal: J Biol Chem Date: 2014-01-27 Impact factor: 5.157
Authors: Teresa M Lee; Daphne T Hsu; Paul Kantor; Jeffrey A Towbin; Stephanie M Ware; Steven D Colan; Wendy K Chung; John L Jefferies; Joseph W Rossano; Chesney D Castleberry; Linda J Addonizio; Ashwin K Lal; Jacqueline M Lamour; Erin M Miller; Philip T Thrush; Jason D Czachor; Hiedy Razoky; Ashley Hill; Steven E Lipshultz Journal: Circ Res Date: 2017-09-15 Impact factor: 17.367
Authors: Nathan R Tucker; Micheal A McLellan; Dongjian Hu; Jiangchuan Ye; Victoria A Parsons; Robert W Mills; Sebastian Clauss; Elena Dolmatova; Marisa A Shea; David J Milan; Nandita S Scott; Mark Lindsay; Steven A Lubitz; Ibrahim J Domian; James R Stone; Honghuang Lin; Patrick T Ellinor Journal: Circ Cardiovasc Genet Date: 2017-12
Authors: A Muravyev; T Vershinina; P Tesner; G Sjoberg; Yu Fomicheva; N Novák Čajbiková; A Kozyreva; S Zhuk; E Mamaeva; S Tarnovskaya; J Jornholt; P Sokolnikova; T Pervunina; E Vasichkina; T Sejersen; A Kostareva Journal: Orphanet J Rare Dis Date: 2022-09-14 Impact factor: 4.303